A phase II study of raltitrexed (‘Tomudex’ ) in patients with hepatocellular carcinoma
- 1 May 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (5) , 500-502
- https://doi.org/10.1023/a:1008249328792
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- ZD1694 (Tomudex): A new thymidylate synthase inhibitor with activity in colorectal cancerEuropean Journal Of Cancer, 1995
- Postoperative Recurrence of Hepatocellular CarcinomaAnnals of Surgery, 1990
- Hepatocellular CarcinomaAnnals of Internal Medicine, 1988
- Clinical trials in primary hepatocellular carcinoma: current status and future directionsCancer Treatment Reviews, 1988